España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
MLV
MLV Initiates Yuma Energy With Buy
MLV Upgrades Rose Rock Midstream To Buy
UPDATE: MLV Initiates Coverage On Agios Pharmaceuticals
MLV Upgrades Rose Rock Midstream To Buy
UPDATE: MLV Initiates Coverage On Agios Pharmaceuticals
UPDATE: MLV & Co. Upgrades Starwood Hotels & Resorts Worldwide
UPDATE: MLV Downgrades LaSalle Hotel Properties
UPDATE: MLV & Co. Upgrades Starwood Hotels & Resorts Worldwide
UPDATE: MLV Downgrades LaSalle Hotel Properties
UPDATE: MLV Initiates Pluristem Therapeutics at Buy on Unique Cell Therapy Platform
UPDATE: MLV Downgrades CapLease to Hold, Raises PT Following American Realty Capital Properties Merger Announcement
Read More...
MLV Recent News
UPDATE: MLV Initiates Starwood Property Trust at Buy with $25.50 on Balance Sheet Strength
UPDATE: MLV Initiates NorthStar Realty Finance at Buy with PT of $6.50 on Valuation
UPDATE: MLV Initiates Buy, $6 PT on Resource Capital Corporation on Return Profile
UPDATE: MLV Initiates Cytokinetics with Buy, $4 PT
MLV Starts Coverage on Crimson Exploration, Gives Buy Rating and $5.50 PT
MLV Starts Coverage on Crimson Exploration, Gives Buy Rating and $5.50 PT
UPDATE: MLV Raises Transcept Pharmaceuticals' PT
UPDATE: MLV Raises Target to $10 on Curis
MLV Maintains Buy, $4 Target on Zalicus Post Settlement
MLV Reiterates Buy, $15 PT on Alnylam Pharmaceuticals
UPDATE: MLV Initiates Buy, $6 PT on Avanir Pharmaceutical
UPDATE: MLV Raises Price Target on Inhibitex to $26
UPDATE: MLV & Co Initiates Buy, $4 Target on Zalicus
UPDATE: MLV Raising Price Target on Cerus Corp.
UPDATE: MLV Raising Price Target on Inhibitex
MLV Maintains Buy on Double Eagle Petroleum
MLV Initiates Coverage of Sunesis Pharmaceuticals with a Buy Rating
MLV Initiates Coverage On Agenus
UPDATE: MLV Raises PT on Aastrom Biosciences to $7.50
MLV Maintains Buy on ArQule
UPDATE: MLV Reiterates Buy on Novavax, Reduces PT to $9.50
MLV Maintains Buy on Genomic Health
MLV Provides Color on Affymax